Home / Inspections / 1327126

FDA Inspection 1327126 — Norwich Pharmaceuticals, Inc.

Norwich Pharmaceuticals, Inc. — FEI 1350044

The FDA completed an inspection of Norwich Pharmaceuticals, Inc. on May 1, 2026 in Norwich, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 1, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Norwich, NY (United States)

Additional Details

Bioanalytical BA/BE

Facility

Other inspections at this facility

  • 1298640 (NAI Wed Dec 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1136679 (VAI Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1043457 (NAI Fri Feb 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 950656 (NAI Fri Oct 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 840195 (NAI Fri Jul 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources